[Nonalcoholic Fatty Liver Disease and Weight Loss].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 40(5): 597-602, 2018 Oct 30.
Article
en Zh
| MEDLINE
| ID: mdl-30404689
ABSTRACT
Nonalcoholic fatty liver disease(NAFLD)refers to hepatic steatosis without other known causes such as alcohol abuse or hepatic virus infection. NAFLD has become a chronic disease worldwide,and its prevalence is constantly growing. Hepatic insulin resistance caused by obesity results in the deposition of triglycerides in the liver,promoting the occurrence and development of NAFLD. Weight loss is the only safe and effective method for NAFLD. Lifestyle intervention plays a cornerstone role in treating NAFLD;however,most patients can not achieve and maintain the ideal body weight by lifestyle intervention alone. Glucagon-like peptide-1 receptor agonist and metabolic surgery are promising treatments for NAFLD.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pérdida de Peso
/
Enfermedad del Hígado Graso no Alcohólico
Tipo de estudio:
Risk_factors_studies
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
Zh
Revista:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
Año:
2018
Tipo del documento:
Article
País de afiliación:
China